Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated (PFO)
PFO trades on NYSE in Finance, Finance Companies. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.59
+0.29% on the day
Market cap
Preferred share: priced separately from the common stock
Revenue
Preferred share: priced separately from the common stock
Net income
Preferred share: priced separately from the common stock
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | PFO on NYSE |
| Sector | Finance |
| Industry | Finance Companies |
| Country | United States |
| IPO year | 1992 |
| SEC CIK | 0000882071 |
| Incorporated in | MD |
Financials
Preferred share: priced separately from the common stock.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2021-04-30 |
| Latest current report CURRENT REPORT | 8-K | 2019-05-02 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-03-09 |
Source: SEC EDGAR submissions feed, 414 recent filings. All filings on EDGAR.
Peers in Finance Companies
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NCZ | Virtus Convertible & Income Fund II Common Shares of Beneficial Interest | $14.28 | -2.26% | $1.1B |
| HQH | abrdn Healthcare Investors Shares of Beneficial Interest | $19.13 | -2.99% | $905.7M |
| BST | BlackRock Science and Technology Trust Common Shares of Beneficial Interest | $50.09 | -0.38% | $1.1B |
| JCAP | Jefferson Capital Inc. | $20.54 | +0.93% | $1.2B |
| PRAA | PRA Group Inc. | $20.47 | +2.40% | $770.7M |
| NCV | Virtus Convertible & Income Fund Common Shares of Beneficial Interest | $15.33 | -1.86% | $1.4B |
| BDJ | Blackrock Enhanced Equity Dividend Trust | $9.59 | -0.10% | $1.7B |
| SWRD | Stewards Inc | $2.50 | -4.21% | $564.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier